Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04771156 · ClinicalTrials.gov registry record · Phase 4

Ketorolac in Palatoplasty

A Phase 4 study of Cleft Lip and Palate, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
Phase 4
Development phase
74
Enrollment target
1
Study location

NCT04771156 is a Phase 4 study of Cleft Lip and Palate that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 74 participants, below the 209-participant average among 5 other Cleft Lip and Palate trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04771156, a Phase 4 study of Cleft Lip and Palate, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
Phase 4
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG Ketorolac

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2021-09-17
Est. Completion 2027-04-01
Phase Phase 4

What the Registry Record Tells You About NCT04771156

The ClinicalTrials.gov registry entry for NCT04771156 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 209-participant average among 5 other Cleft Lip and Palate trials with a reported enrollment target (65% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cleft Lip and Palate appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04771156 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04771156 about?

NCT04771156 is a clinical study titled "Ketorolac in Palatoplasty". The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively

What is the current status of trial NCT04771156?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2021-09-17. Estimated completion is 2027-04-01.

What conditions does trial NCT04771156 study?

This clinical trial studies the following conditions: Cleft Lip and Palate.

What interventions are being tested in trial NCT04771156?

The interventions under investigation include: Placebo (DRUG), Ketorolac (DRUG).

Who is sponsoring clinical trial NCT04771156?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04771156 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cleft Lip and Palate

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.